Align Technology, Inc. (NASDAQ:ALGN) Projects Margin Recovery While Operational Restructuring Drives Near-Term Pressure

Align enters a period of active operational change that tightens near-term cost structure while leaving valuation upside under WMDST’s framework. Technical momentum favors downside pressure now; fundamentals show margin improvement targets alongside modest revenue growth.

Recent News

On July 30, 2025 Align announced a restructuring program that will reduce global headcount, optimize manufacturing footprint and incur approximately $150 million–$170 million of one‑time charges in H2 2025; the company expects roughly $50 million–$60 million of those charges in Q3 2025. The release also noted commercial rollouts in Malaysia for the Invisalign System with mandibular advancement and the Invisalign Palatal Expander, plus a July collaboration tied to a branded placement in a major film opening in August 2025.

Technical Analysis

ADX & Directional Indicators: ADX at 40.64 signals a very strong trend. DI+ sits at 11.49 and trends decreasing, while DI– sits at 30.97 and shows a dip-and-reversal pattern; both directional readings imply strengthening downside pressure that supports a bearish near-term price bias.

MACD: MACD equals -5.86 with a peak-and-reversal trend, indicating bearish momentum; nevertheless the MACD currently sits above its signal line (-6.31), which registers as a short-lived bullish crossover signal amid an overall weakening momentum backdrop.

MRO: MRO at -32.44 indicates price sits below the WMDST target and therefore carries potential upward pressure toward that target; the MRO trend registers a peak-and-reversal, tempering the strength of that upside potential in the immediate term.

RSI & Volatility: RSI at 39.77 with a peak-and-reversal trend indicates bearish momentum without oversold extremity. Volatility metrics show 42‑day volatility of 6% and 52‑week volatility of 3%, implying recent moves carry higher short-term amplitude versus yearlong baseline.

Price vs Moving Averages and Bands: Last close at $124.88 sits below the 20‑day average $131.62, 50‑day average $149.60 and 200‑day average $180.77, a multi‑timeframe bearish configuration. Price trades near the lower Bollinger band (lower 1x = $127.99, lower 2x = $124.37), consistent with compression near support. The 12‑day EMA trends down and Ichimoku lines (Tenkan $131.19, Kijun $136.11) remain above price, reinforcing short-term resistance ahead.

Volume & Beta: Daily volume near 1.59M exceeds the 10‑day average of ~1.18M, indicating elevated participation on recent moves. Short‑term beta (42‑day) at 1.95 shows high sensitivity to market swings, while 52‑week beta at 1.30 reflects above‑average market correlation over a longer horizon.

 


Fundamental Analysis

Profitability & Margins: Total revenue recorded at $1,012,449,000. Operating income equals $163,033,000, delivering an operating (EBIT) margin of 16.103%, which improved QoQ by 16.57% but declined YoY by 7.048%. That EBIT margin sits below the industry peer mean of 18.499% and below the industry peer median of 17.478% while remaining above the industry peer low.

Cash Flow & Liquidity: Operating cash flow equals $128,650,000 and free cash flow equals $107,171,000, producing a free cash flow yield of 0.78% and a cash conversion ratio of 2.23709. Cash and short‑term investments total $901,157,000, with a cash ratio of 45.16% and a current ratio of 1.2268, indicating liquidity that can fund restructuring actions without immediate financing stress.

Capital Structure & Coverage: Total debt stands at $123,020,000, producing a debt-to-assets ratio of 1.978% and debt-to-equity of 3.144%; interest coverage measures at 152.23x, demonstrating substantial ability to service interest expense.

Returns & Growth: Return on assets registers 2.023% and return on equity 3.185%, each improving QoQ and YoY. Revenue growth year‑over‑year equals 8.831% while quarter‑over‑quarter revenue growth shows a -311.416% figure in the provided series; earnings growth year‑over‑year equals 33.954% while QoQ earnings growth contracted by 233.026% in the supplied metrics. Gross margin holds near 69.941%.

Valuation & Earnings Detail: Trailing EPS registered at $2.49 versus an estimate of $2.57, producing an EPS surprise of -3.11%. Trailing P/E approximates 76.09x and forward P/E about 70.70x. Enterprise value-to-revenue registers near 12.80; enterprise multiple stands near 63.63x. WMDST values the stock as under‑valued under the current model, noting that the company’s margin targets from restructuring form the principal catalyst for re‑rating.

MOST-RECENT QUARTERLY REPORT
REPORT PERIOD ENDING: 2025-06-30
REPORT DATE: 2025-07-30
NEXT REPORT DATE: 2025-10-29
CASH FLOW  Begin Period Cash Flow 874.1 M
 Operating Cash Flow 128.7 M
 Capital Expenditures -21.48 M
 Change In Working Capital -64.94 M
 Dividends Paid
 Cash Flow Delta 28.3 M
 End Period Cash Flow 902.3 M
 
INCOME STATEMENT REVENUE
 Total Revenue 1.0 B
 Forward Revenue 377.7 M
COSTS
 Cost Of Revenue 304.3 M
 Depreciation 40.6 M
 Depreciation and Amortization 40.6 M
 Research and Development 96.4 M
 Total Operating Expenses 849.4 M
PROFITABILITY
 Gross Profit 708.1 M
 EBITDA 203.6 M
 EBIT 163.0 M
 Operating Income 163.0 M
 Interest Income 2.9 M
 Interest Expense
 Net Interest Income 2.9 M
 Income Before Tax 173.5 M
 Tax Provision 48.9 M
 Tax Rate 28.186 %
 Net Income 124.6 M
 Net Income From Continuing Operations 124.6 M
EARNINGS
 EPS Estimate 2.57
 EPS Actual 2.49
 EPS Difference -0.08
 EPS Surprise -3.113 %
 Forward EPS 2.56
 
BALANCE SHEET ASSETS
 Total Assets 6.2 B
 Intangible Assets 594.6 M
 Net Tangible Assets 3.3 B
 Total Current Assets 2.4 B
 Cash and Short-Term Investments 901.2 M
 Cash 901.2 M
 Net Receivables 1.1 B
 Inventory 243.8 M
 Long-Term Investments 250.7 M
LIABILITIES
 Accounts Payable 114.4 M
 Short-Term Debt
 Total Current Liabilities 2.0 B
 Net Debt
 Total Debt 123.0 M
 Total Liabilities 2.3 B
EQUITY
 Total Equity 3.9 B
 Retained Earnings 2.4 B
VALUATION & PER-SHARE METRICS EQUITY & PER-SHARE METRICS
 Book Value Per-Share 53.98
 Shares Outstanding 72.486 M
 Revenue Per-Share 13.97
VALUATION
 Market Capitalization 13.7 B
 Enterprise Value 13.0 B
 Enterprise Multiple 63.626
Enterprise Multiple QoQ -10.575 %
Enterprise Multiple YoY -27.048 %
Enterprise Multiple IPRWA high: 123.29
median: 110.415
mean: 94.621
ALGN: 63.626
low: -147.649
 EV/R 12.796
CAPITAL STRUCTURE
 Asset To Equity 1.589
 Asset To Liability 2.697
 Debt To Capital 0.03
 Debt To Assets 0.02
Debt To Assets QoQ 1.854 %
Debt To Assets YoY 295.6 %
Debt To Assets IPRWA high: 0.843
mean: 0.304
median: 0.292
ALGN: 0.02
low: 0.0
 Debt To Equity 0.031
Debt To Equity QoQ 0.64 %
Debt To Equity YoY 283.883 %
Debt To Equity IPRWA high: 3.369
mean: 0.642
median: 0.579
ALGN: 0.031
low: -0.395
PRICE-BASED VALUATION
 Price To Book (P/B) 3.51
Price To Book QoQ 1.155 %
Price To Book YoY -32.171 %
Price To Book IPRWA high: 16.759
median: 6.869
mean: 6.33
ALGN: 3.51
low: -5.981
 Price To Earnings (P/E) 76.087
Price To Earnings QoQ -10.063 %
Price To Earnings YoY -29.561 %
Price To Earnings IPRWA high: 249.6
mean: 137.484
median: 121.658
ALGN: 76.087
low: -167.592
 PE/G Ratio 4.502
 Price To Sales (P/S) 13.564
Price To Sales QoQ 0.896 %
Price To Sales YoY -28.257 %
Price To Sales IPRWA high: 73.117
mean: 32.726
median: 24.499
ALGN: 13.564
low: 0.6
FORWARD MULTIPLES
Forward P/E 70.7
Forward PE/G 4.183
Forward P/S 36.363
EFFICIENCY OPERATIONAL
 Operating Leverage 6.054
ASSET & SALES
 Asset Turnover Ratio 0.164
Asset Turnover Ratio QoQ 3.352 %
Asset Turnover Ratio YoY -1.622 %
Asset Turnover Ratio IPRWA high: 0.412
ALGN: 0.164
median: 0.124
mean: 0.121
low: 0.008
 Receivables Turnover 0.93
Receivables Turnover Ratio QoQ -2.331 %
Receivables Turnover Ratio YoY -10.929 %
Receivables Turnover Ratio IPRWA high: 3.133
mean: 1.747
median: 1.672
ALGN: 0.93
low: 0.374
 Inventory Turnover 1.241
Inventory Turnover Ratio QoQ 3.917 %
Inventory Turnover Ratio YoY 9.494 %
Inventory Turnover Ratio IPRWA high: 2.014
ALGN: 1.241
mean: 0.639
median: 0.568
low: 0.084
 Days Sales Outstanding (DSO) 98.158
CASH CYCLE
 Cash Conversion Cycle Days (CCC) 136.363
Cash Conversion Cycle Days QoQ -0.229 %
Cash Conversion Cycle Days YoY 0.538 %
Cash Conversion Cycle Days IPRWA high: 448.876
mean: 171.549
median: 167.784
ALGN: 136.363
low: -175.55
CAPITAL DEPLOYMENT
 Cash Conversion Ratio 2.237
 CapEx To Revenue -0.021
 CapEx To Depreciation -0.529
 
CAPITAL, LIQUIDITY & COVERAGE CAPITAL STRUCTURE
 Total Capital 3.9 B
 Net Invested Capital 3.9 B
 Invested Capital 3.9 B
 Net Tangible Assets 3.3 B
 Net Working Capital 452.6 M
LIQUIDITY
 Cash Ratio 0.452
 Current Ratio 1.227
Current Ratio QoQ 1.684 %
Current Ratio YoY 3.749 %
Current Ratio IPRWA high: 19.146
mean: 2.569
median: 1.718
ALGN: 1.227
low: 0.027
 Quick Ratio 1.105
Quick Ratio QoQ 2.034 %
Quick Ratio YoY 4.679 %
Quick Ratio IPRWA high: 18.509
mean: 1.895
median: 1.167
ALGN: 1.105
low: 0.315
COVERAGE & LEVERAGE
 Debt To EBITDA 0.604
 Cost Of Debt 0.637 %
 Interest Coverage Ratio 152.225
Interest Coverage Ratio QoQ 20.517 %
Interest Coverage Ratio YoY 171.688 %
Interest Coverage Ratio IPRWA ALGN: 152.225
high: 52.298
mean: 15.458
median: 11.456
low: -88.481
 Operating Cash Flow Ratio 0.052
TIMING / LIQUIDITY
 Days Payables Outstanding (DPO) 36.575
DIVIDENDS
 Dividend Coverage Ratio
 Dividend Payout Ratio
 Dividend Rate
 Dividend Yield
PERFORMANCE GROWTH
 Asset Growth Rate 1.905 %
 Revenue Growth 3.389 %
Revenue Growth QoQ -311.416 %
Revenue Growth YoY 8.831 %
Revenue Growth IPRWA high: 26.158 %
median: 8.281 %
mean: 6.362 %
ALGN: 3.389 %
low: -19.222 %
 Earnings Growth 16.901 %
Earnings Growth QoQ -233.026 %
Earnings Growth YoY 33.954 %
Earnings Growth IPRWA high: 166.667 %
ALGN: 16.901 %
mean: 11.202 %
median: 9.851 %
low: -180.612 %
MARGINS
 Gross Margin 69.941 %
Gross Margin QoQ 0.706 %
Gross Margin YoY -0.455 %
Gross Margin IPRWA high: 91.006 %
ALGN: 69.941 %
median: 63.683 %
mean: 62.065 %
low: -7.085 %
 EBIT Margin 16.103 %
EBIT Margin QoQ 16.57 %
EBIT Margin YoY -7.048 %
EBIT Margin IPRWA high: 33.709 %
mean: 18.499 %
median: 17.478 %
ALGN: 16.103 %
low: -200.872 %
 Return On Sales (ROS) 16.103 %
Return On Sales QoQ 16.57 %
Return On Sales YoY -7.048 %
Return On Sales IPRWA high: 39.857 %
mean: 19.021 %
median: 18.374 %
ALGN: 16.103 %
low: -193.243 %
CASH FLOW
 Free Cash Flow (FCF) 107.2 M
 Free Cash Flow Yield 0.78 %
Free Cash Flow Yield QoQ 275.0 %
Free Cash Flow Yield YoY 42.596 %
Free Cash Flow Yield IPRWA high: 4.685 %
ALGN: 0.78 %
mean: 0.674 %
median: 0.66 %
low: -19.501 %
 Free Cash Growth 291.321 %
Free Cash Growth QoQ -425.168 %
Free Cash Growth YoY -35.451 %
Free Cash Growth IPRWA high: 310.383 %
ALGN: 291.321 %
mean: 81.236 %
median: 14.619 %
low: -376.098 %
 Free Cash To Net Income 0.86
 Cash Flow Margin 10.155 %
 Cash Flow To Earnings 0.825
VALUE & RETURNS
 Economic Value Added 0.04
 Return On Assets (ROA) 2.023 %
Return On Assets QoQ 33.62 %
Return On Assets YoY 29.018 %
Return On Assets IPRWA high: 16.404 %
ALGN: 2.023 %
mean: 1.743 %
median: 1.686 %
low: -26.44 %
 Return On Capital Employed (ROCE) 3.86 %
 Return On Equity (ROE) 0.032
Return On Equity QoQ 29.63 %
Return On Equity YoY 23.93 %
Return On Equity IPRWA high: 0.175
ALGN: 0.032
median: 0.029
mean: 0.028
low: -0.524
 DuPont ROE 3.234 %
 Return On Invested Capital (ROIC) 2.992 %
Return On Invested Capital QoQ 26.405 %
Return On Invested Capital YoY -118.802 %
Return On Invested Capital IPRWA high: 5.672 %
ALGN: 2.992 %
median: 2.571 %
mean: 2.21 %
low: -19.888 %

Six-Week Outlook

Near term, technicals point to continued downside vulnerability while restructuring announcements supply a clear catalyst window. Expect price to face resistance at falling short‑term EMAs and the Ichimoku Kijun, while any stabilization in MACD momentum or a sustained move of RSI away from the current peak‑and‑reversal could reduce downside momentum. Operational updates on restructuring, notably the timing and magnitude of the expected $150M–$170M charges and any disclosure of realized cost saves, will act as primary fundamental catalysts that can shift valuation perception. Liquidity and coverage metrics provide the company room to execute the plan without immediate capital raises, supporting upside potential if operational targets translate into the margin improvements management projects.

About Align Technology, Inc.

Align Technology, Inc. (NASDAQ:ALGN) revolutionizes the orthodontic landscape with its cutting-edge dental solutions. Founded in 1997 and headquartered in Tempe, Arizona, the company spearheads advancements in dental technology, primarily through its flagship product, the Invisalign system. This innovative series of clear aligners provides a discreet and effective alternative to traditional metal braces, catering to a diverse range of orthodontic needs, from minor corrections to comprehensive treatments for both adults and children. Beyond Invisalign, Align Technology enhances dental care with the iTero intraoral scanning system. This state-of-the-art digital platform streamlines restorative and orthodontic procedures by offering precise diagnostic and treatment planning tools, enabling the creation of customized dental appliances. The company’s commitment to technological advancement also includes 3D printing solutions and sophisticated software tools like the Invisalign outcome simulator and TimeLapse technology, which aid practitioners in visualizing treatment progress and outcomes. Align Technology maintains a global presence, with operations in the United States, Switzerland, and other international markets. By integrating technology with patient-focused care, Align Technology continues to transform dental practices, fostering improved patient communication and satisfaction while boosting confidence through enhanced smiles worldwide.



© 2025 WMDST — The World’s Most Dangerous Swing Trader. All rights reserved.